4.7 Article

How segmentation methods affect hippocampal radiomic feature accuracy in Alzheimer's disease analysis?

期刊

EUROPEAN RADIOLOGY
卷 32, 期 10, 页码 6965-6976

出版社

SPRINGER
DOI: 10.1007/s00330-022-09081-y

关键词

Radiomic features; Hippocampus segmentation; Alzheimer's disease; Machine learning; Magnetic resonance imaging

资金

  1. Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]
  2. DOD ADNI (Department of Defense) [W81XWH-12-2-0012]
  3. National Institute on Aging
  4. National Institute of Biomedical Imaging and Bioengineering
  5. AbbVie
  6. Alzheimer's Association
  7. Alzheimer's Drug Discovery Foundation
  8. Araclon Biotech
  9. BioClinica, Inc.
  10. Biogen
  11. CereSpir, Inc.
  12. Cogstate
  13. Eisai Inc.
  14. Elan Pharmaceuticals, Inc.
  15. Eli Lilly and Company
  16. EuroImmun
  17. F. Hoffmann-La Roche Ltd.
  18. Genentech, Inc.
  19. Fujirebio
  20. GE Healthcare
  21. IXICO Ltd.
  22. Janssen Alzheimer Immunotherapy Research & Development, LLC
  23. Johnson & Johnson Pharmaceutical Research & Development LLC
  24. Lumosity
  25. Lundbeck
  26. Merck Co., Inc.
  27. Meso Scale Diagnostics, LLC
  28. NeuroRx Research
  29. Neurotrack Technologies
  30. Novartis Pharmaceuticals Corporation
  31. Pfizer Inc.
  32. Piramal Imaging
  33. Servier
  34. Takeda Pharmaceutical Company
  35. Transition Therapeutics
  36. Canadian Institutes of Health Research
  37. Bristol-Myers Squibb Company

向作者/读者索取更多资源

This study investigates how different hippocampal segmentation methods affect the accuracy of hippocampal radiomic features (HRFs) in Alzheimer's disease (AD) analysis. The results show that HRFs exhibit high consistency across different segmentation methods and the best performance in AD classification is obtained when HRFs are extracted using the naive majority voting method with a more sufficient segmentation and relatively low hippocampal segmentation accuracy.
Objectives Hippocampal radiomic features (HRFs) can serve as biomarkers in Alzheimer's disease (AD). However, how different hippocampal segmentation methods affect HRFs in AD is still unknown. The aim of the study was to investigate how different segmentation methods affect HRF accuracy in AD analysis. Methods A total of 1650 subjects were identified from the Alzheimer's Disease Neuroimaging Initiative database (ADNI). The mini-mental state examination (MMSE) and Alzheimer's disease assessment scale (ADAS-cog13) were also adopted. After calculating the HRFs of intensity, shape, and textural features from each side of the hippocampus in structural magnetic resonance imaging (sMRI), the consistency of HRFs calculated from 7 different hippocampal segmentation methods was validated, and the performance of machine learning-based classification of AD vs. normal control (NC) adopting the different HRFs was also examined. Additional 571 subjects from the European DTI Study on Dementia database (EDSD) were to validate the consistency of results. Results Between different segmentations, HRFs showed a high measurement consistency (R > 0.7), a high significant consistency between NC, mild cognitive impairment (MCI), and AD (T-value plot, R > 0.8), and consistent significant correlations between HRFs and MMSE/ADAS-cog13 (p < 0.05). The best NC vs. AD classification was obtained when the hippocampus was sufficiently segmented by primitive majority voting (threshold = 0.2). High consistent results were reproduced from independent EDSD cohort. Conclusions HRFs exhibited high consistency across different hippocampal segmentation methods, and the best performance in AD classification was obtained when HRFs were extracted by the naive majority voting method with a more sufficient segmentation and relatively low hippocampus segmentation accuracy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据